John D Catravas Selected Research

Nitric Oxide (Nitrogen Monoxide)

1/2017	Hyper-activation of pp60Src limits nitric oxide signaling by increasing asymmetric dimethylarginine levels during acute lung injury.
7/2011	C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow.
11/2006	Nitric oxide and the endothelium: history and impact on cardiovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John D Catravas Research Topics

Disease

17	Lung Injury 02/2024 - 10/2004
13	Inflammation (Inflammations) 12/2022 - 10/2007
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2019
9	Acute Lung Injury 01/2022 - 05/2010
6	Fibrosis (Cirrhosis) 01/2022 - 01/2019
5	Asthma (Bronchial Asthma) 01/2022 - 03/2005
5	Sepsis (Septicemia) 11/2020 - 09/2007
4	Body Weight (Weight, Body) 01/2022 - 10/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 01/2021
3	Neoplasms (Cancer) 05/2020 - 06/2013
3	Pulmonary Hypertension 01/2019 - 02/2002
3	Pneumonia (Pneumonitis) 12/2016 - 10/2007
3	Edema (Dropsy) 10/2012 - 10/2008
2	COVID-19 01/2023 - 01/2020
2	Idiopathic Pulmonary Fibrosis 01/2022 - 07/2020
2	Hypoxia (Hypoxemia) 10/2008 - 02/2002
1	Pulmonary Arterial Hypertension 08/2022
1	Alcoholism (Alcohol Abuse) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Disease Progression 01/2022
1	Obesity 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Lung Diseases (Lung Disease) 05/2020
1	Airway Obstruction (Choking) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2018
1	Familial Primary Pulmonary Hypertension 01/2015
1	Vascular Remodeling 08/2014
1	Right Ventricular Hypertrophy 08/2014
1	Pneumococcal Pneumonia 10/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
10	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2024 - 10/2007
9	Hydrochloric Acid (Hydrogen Chloride)FDA Link 02/2024 - 01/2019
5	CollagenIBA 01/2022 - 01/2020
4	CytokinesIBA 12/2022 - 10/2007
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
4	Estrogens (Estrogen)FDA Link 10/2021 - 02/2002
3	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2021 - 01/2020
3	LipopolysaccharidesIBA 01/2017 - 02/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2006
3	EndotoxinsIBA 12/2016 - 10/2007
2	TAS-116IBA 02/2024 - 01/2022
2	ChemokinesIBA 12/2022 - 10/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 10/2012
2	Vasodilator Agents (Vasodilators)IBA 08/2022 - 01/2015
2	SARS-CoV-2 spike proteinIBA 01/2022 - 01/2021
2	InflammasomesIBA 01/2022 - 01/2022
2	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 03/2009
2	Extracellular Matrix ProteinsIBA 07/2020 - 05/2020
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 11/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2018 - 12/2016
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017 - 05/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014 - 11/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2010 - 11/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2008 - 10/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2007 - 02/2002
1	AcetoneIBA 02/2024
1	Gefitinib (Iressa)FDA Link 02/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2024
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	ElastinIBA 01/2022
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	nintedanibIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	pirfenidoneIBA 01/2022
1	LipidsIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Estrogen ReceptorsIBA 10/2021
1	Phytoestrogens (Phytoestrogen)IBA 10/2021
1	GenisteinIBA 10/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	ActomyosinIBA 01/2021
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2020
1	ProteomeIBA 07/2020
1	AcidsIBA 05/2020
1	AntidotesIBA 05/2020
1	remdesivirIBA 01/2020
1	QuercetinIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 02/2018
1	Protein Tyrosine PhosphatasesIBA 02/2018
1	JMS-053IBA 02/2018
1	Therapeutic UsesIBA 11/2017
1	Thiamine (Aneurin)FDA Link 11/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2017
1	ezrinIBA 12/2016
1	moesinIBA 12/2016
1	Histone Deacetylase InhibitorsIBA 12/2015
1	NADPH Oxidase 4IBA 08/2014
1	MonocrotalineIBA 08/2014
1	dimethylargininaseIBA 03/2014
1	Virulence Factors (Pathogenicity Factors)IBA 10/2012
1	Streptococcus pneumoniae plY proteinIBA 10/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2012

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2019
2	Estrogen Replacement Therapy 03/2009 - 02/2002